Lexicon Pharmaceuticals announced that it will present data on diabetic peripheral neuropathic pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025) in ...

DUBLIN--(BUSINESS WIRE)--The "Diabetic Neuropathic Pain Ongoing Global Clinical Trials Analysis and Outlook" report has been added to ResearchAndMarkets.com's offering. Diabetic Neuropathic Pain ...

However, prevalence was found to plateau over time, suggesting neuropathic pain may be isolated or intermittent events in some patients with type 1 diabetes. “The features and burden of neuropathic ...

Diabetes is often complicated by diabetic peripheral neuropathic pain (DPNP). Current medications for pain of this origin carry notable side effects or efficacy problems. Duloxetine is a dual ...

Presenters: Belinda Hardin, PharmD, BCPS, Senior Director, Medical Communications, and Suma Gopinathan, M.S, Ph.D., Senior Vice President, Discovery, Lexicon Pharmaceuticals Diabetic neuropathy is a ...

BOSTON--(BUSINESS WIRE)--NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases today announced its plans to ...

Dr Cuevas-Trisan covered the evaluation and management of diabetic peripheral neuropathic pain during his presentation at PAINWeek 2017. The following article features coverage from PAINWeek 2017 in ...

THE WOODLANDS, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX) today announced that three poster presentations will be delivered during the 84th Scientific ...

Peripheral neuropathic pain is one of the most common and debilitating complications of diabetes. Several genes have been shown to be effective in reducing neuropathic pain in animal models of ...

Selective serotonin reuptake inhibitors (SSRIs) and other types of antidepressents have demonstrated varying efficacy for diabetic neuropathy, and have generally been found to be less effective than ...

Managing diabetic neuropathic pain Neuropathy is one of the most common diabetic comorbidities — affecting about 60% to 70% of patients. Managing glucose levels is the most direct way to prevent nerve ...